Clinical Application of New Advances in the Treatment of Head and Neck Cancer

Download these slides for quick highlights on treating patients with head and neck cancer with the latest biomarker-driven therapies.

Aarti Bhatia, MD, MPH Barbara Burtness, MD Elisabeth King, RN, FNP, AGN, AOCNP Dan P. Zandberg, MD Released: April 9, 2021

Downloadable slides based on an expert video reviewing the current standard of care for your patients with advanced metastatic head and neck cancer.

Barbara Burtness, MD Released: November 11, 2020

Downloadable slides review the optimal use of immune checkpoint inhibitors in the frontline setting in patients with advanced metastatic head and neck cancer.

Barbara Burtness, MD Released: November 10, 2020

Downloadable slides review current clinical trials with immunotherapies for patients with advanced metastatic head and neck cancer.

Barbara Burtness, MD Released: January 5, 2021

Downloadable slides to review the rationale for treating NTRK fusions in patients with head and neck cancer.

Aarti Bhatia, MD, MPH Released: December 21, 2020

Download these slides to review how and when to test for NTRK fusions in patients with head and neck cancer.

Aarti Bhatia, MD, MPH Released: January 5, 2021

Download these slides to review the use of NTRK inhibitors in patients with head and neck cancer.

Aarti Bhatia, MD, MPH Released: December 22, 2020

Download these slides for quick highlights of recommended management strategies for patients with head and neck cancer experiencing immune-related adverse events.

Elisabeth King, RN, FNP, AGN, AOCNP Released: March 9, 2021

Download these slides for quick highlights on the importance of molecular testing for patients with head and neck cancer.

Elisabeth King, RN, FNP, AGN, AOCNP Released: March 18, 2021

Download these slides for quick highlights on the role of the immune system and immune escape in patients with head and neck cancer.

Dan P. Zandberg, MD Released: March 22, 2021

Download these slides for quick highlights on immunotherapy biomarkers in patients with head and neck cancer.

Dan P. Zandberg, MD Released: March 22, 2021